Marcin Kaczor

895 total citations
17 papers, 391 citations indexed

About

Marcin Kaczor is a scholar working on Rheumatology, Hematology and Cancer Research. According to data from OpenAlex, Marcin Kaczor has authored 17 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Marcin Kaczor's work include Systemic Lupus Erythematosus Research (4 papers), Health Sciences Research and Education (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Marcin Kaczor is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), Health Sciences Research and Education (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Marcin Kaczor collaborates with scholars based in Poland, United Kingdom and Hungary. Marcin Kaczor's co-authors include Marek Sanak, Jacek Musiał, Magdalena Celińska‐Löwenhoff, Jan Kulig, A Szczeklik, Piotr Richter, Marek Sierżęga, Piotr Kołodziejczyk, Teresa Iwaniec and Anetta Undas and has published in prestigious journals such as British Journal of Cancer, Thrombosis and Haemostasis and European Journal of Neurology.

In The Last Decade

Marcin Kaczor

17 papers receiving 380 citations

Peers

Marcin Kaczor

RHEUM

HEMAT

GHP

Paola Sabrina Buonuomo Italy

Solange Mongoue‐Tchokote United States

Anne Timmermans Netherlands

John Waller United Kingdom

Pascal Chaı̈bi France

Friso L. H. Muntinghe Netherlands

Shuyi Wei China

Jill Moormeier United States

Frédéríc Gomez France

Gina Villani United States

Paola Sabrina Buonuomo Italy

Marcin Kaczor

45 ×0.4

121 ×1.4

71 ×0.9

RHEUM

44 ×0.6

HEMAT

33 ×0.4

GHP

Citations per year, relative to Marcin Kaczor Marcin Kaczor (= 1×) peers Paola Sabrina Buonuomo

Countries citing papers authored by Marcin Kaczor

Since Specialization

Citations

This map shows the geographic impact of Marcin Kaczor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcin Kaczor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcin Kaczor more than expected).

Fields of papers citing papers by Marcin Kaczor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcin Kaczor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcin Kaczor. The network helps show where Marcin Kaczor may publish in the future.

Co-authorship network of co-authors of Marcin Kaczor

This figure shows the co-authorship network connecting the top 25 collaborators of Marcin Kaczor. A scholar is included among the top collaborators of Marcin Kaczor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcin Kaczor. Marcin Kaczor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Rejdak, Konrad, Piotr Fiedor, Robert Bonek, et al.. (2023). Amantadine in unvaccinated patients with early, mild to moderate COVID‐19: A randomized, placebo‐controlled, double‐blind trial. European Journal of Neurology. 31(1). e16045–e16045. 5 indexed citations

Bartosik-Psujek, Halina, et al.. (2021). Cladribine tablets versus other disease-modifying oral drugs in achieving no evidence of disease activity (NEDA) in multiple sclerosis–A systematic review and network meta-analysis. Multiple Sclerosis and Related Disorders. 49. 102769–102769. 9 indexed citations

Kaczor, Marcin, et al.. (2019). Critical appraisal of clinical trials in oncology — part I. Oncology in Clinical Practice. 15(2). 89–103. 1 indexed citations

Iwaniec, Teresa, et al.. (2017). Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome. Thrombosis Research. 153. 90–94. 39 indexed citations

Sierżęga, Marek, Marcin Kaczor, Piotr Kołodziejczyk, et al.. (2017). Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331. British Journal of Cancer. 117(2). 266–273. 89 indexed citations

Iwaniec, Teresa, et al.. (2016). Identification of patients with triple antiphospholipid antibody positivity is platform and method independent. Polskie Archiwum Medycyny Wewnętrznej. 126(1-2). 19–24. 17 indexed citations

Iwaniec, Teresa, et al.. (2015). Clinical utility of automated chemiluminescent antiphospholipid antibody assay. Thrombosis Research. 136(5). 1033–1039. 13 indexed citations

Kaczor, Marcin, Marta Seczyńska, Wojciech Szczeklik, & Marek Sanak. (2014). IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: Systematic review of its prevalence in chronic hepatitis C patients and general population frequency. Pharmacological Reports. 67(2). 260–266. 4 indexed citations

Kunz, Regina, É. Nagy, S.F.P.J. Coppus, et al.. (2009). How far did we get? How far to go? A European survey on postgraduate courses in evidence‐based medicine. Journal of Evaluation in Clinical Practice. 15(6). 1196–1204. 17 indexed citations

10.

Kulier, Regina, Julie Hadley, Susanne Weinbrenner, et al.. (2008). Harmonising Evidence-based medicine teaching: a study of the outcomes of e-learning in five European countries. BMC Medical Education. 8(1). 27–27. 50 indexed citations

11.

Kaczor, Marcin & Rafał Wójcik. (2007). Original paper An economic analysis of TNF-α antagonists for rheumatoid arthritis in Polish settings. Reumatologia/Rheumatology. 45(5). 268–275. 2 indexed citations

12.

Kaczor, Marcin, et al.. (2007). The prevalence of alpha1-antitrypsin deficiency in a representative population sample from Poland. Respiratory Medicine. 101(12). 2520–2525. 23 indexed citations

13.

Kaczor, Marcin, Marek Sanak, & A Szczeklik. (2007). Molecular diagnostics of α₁-antitrypsin deficiency. Expert Opinion on Medical Diagnostics. 1(2). 253–265. 4 indexed citations

14.

Coppus, S.F.P.J., José Ignacio Emparanza, Julie Hadley, et al.. (2007). A clinically integrated curriculum in Evidence-based Medicine for just-in-time learning through on-the-job training: The EU-EBM project. BMC Medical Education. 7(1). 46–46. 41 indexed citations

15.

Kaczor, Marcin, Marek Sanak, & A Szczeklik. (2007). Rapid and Inexpensive Detection of α1-Antitrypsin Deficiency-Related Alleles S and Z by a Real-Time Polymerase Chain Reaction Suitable for a Large-Scale Population-Based Screening. Journal of Molecular Diagnostics. 9(1). 99–104. 23 indexed citations

16.

Celińska‐Löwenhoff, Magdalena, Marcin Kaczor, Jacek Musiał, & Anetta Undas. (2004). New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thrombosis and Haemostasis. 91(6). 1065–1077. 52 indexed citations

17.

Kaczor, Marcin, et al.. (1986). [Informing the patients].. PubMed. 24–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact